首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-{alpha}/{beta}-induced ubiquitin-like protein.
【24h】

The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-{alpha}/{beta}-induced ubiquitin-like protein.

机译:UbcH8泛素E2酶也是ISG15的E2酶,ISG15是IFN-α/β诱导的泛素样蛋白。

获取原文
获取原文并翻译 | 示例
       

摘要

Ubiquitin-(Ub) like proteins (Ubls) are conjugated to their targets by an enzymatic cascade involving an E1 activating enzyme, an E2 conjugating enzyme, and in some cases an E3 ligase. ISG15 is a Ubl that is conjugated to cellular proteins after IFN-alpha/beta stimulation. Although the E1 enzyme for ISG15 (Ube1L/E1(ISG15)) has been identified, the identities of the downstream components of the ISG15 conjugation cascade have remained elusive. Here we report the purification of an E2 enzyme for ISG15 and demonstrate that it is UbcH8, an E2 that also functions in Ub conjugation. In vitro assays with purified Ub E2 enzymes and in vivo RNA interference assays indicate that UbcH8 is a major E2 enzyme for ISG15 conjugation. These results indicate that the ISG15 conjugation pathway overlaps or converges with the Ub conjugation pathway at the level of a specific E2 enzyme. Furthermore, these results raise the possibility that the ISG15 conjugation pathway might use UbcH8-competent Ub ligases in vivo. As an initial test of this hypothesis, we have shown that a UbcH8-competent Ub ligase conjugates ISG15 to a specific target in vitro. These results challenge the concept that Ub and Ubl conjugation pathways are strictly parallel and nonoverlapping and have important implications for understanding the regulation and function of ISG15 conjugation in the IFN-alpha/beta response.
机译:泛素-(Ub)样蛋白(Ubls)通过涉及E1活化酶,E2缀合酶,在某些情况下还包括E3连接酶的酶促级联反应与其靶标结合。 ISG15是Ubl,在IFN-α/β刺激后与细胞蛋白缀合。尽管已确定了ISG15的E1酶(Ube1L / E1(ISG15)),但ISG15偶联级联反应下游成分的身份仍然难以捉摸。在这里,我们报告了ISG15的E2酶的纯化,并证明它是UbcH8,也是在Ub偶联中起作用的E2。用纯化的Ub E2酶进行的体外测定和体内RNA干扰测定表明,UbcH8是ISG15偶联的主要E2酶。这些结果表明,ISG15结合途径在特定的E2酶水平上与Ub结合途径重叠或收敛。此外,这些结果增加了ISG15偶联途径可能在体内使用具有UbcH8能力的Ub连接酶的可能性。作为对该假设的初步检验,我们已经证明了具有UbcH8能力的Ub连接酶在体外将ISG15与特定靶标结合。这些结果挑战了Ub和Ubl偶联途径严格平行且不重叠的概念,对理解ISG15偶联在IFN-α/β反应中的调控和功能具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号